Literature DB >> 1335540

Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes.

G A Zapata1, W F Vann, Y Rubinstein, C E Frasch.   

Abstract

Strains of Neisseria meningitidis express one of two porin proteins. These porins have been identified as the class 2 and class 3 proteins, and express serotype-specific epitopes. The gene for the class 3 protein was amplified by the polymerase chain reaction from the DNA of a serotype 4 strain as a 1025 bp fragment. The nucleotide sequence of this gene was determined and compared with two recently published sequences. On the basis of this comparison we have identified two major variable regions in the translated protein sequence, VR1 and VR2, that may be associated with serotype specificity. Three other variable regions were also identified. The sequences in the VR1 and VR2 regions from five additional group B N. meningitidis strains of serotypes 1, 4, 8, 12, and 15, all expressing class 3 proteins, were determined. The VR1 and VR2 regions were variable and were flanked by highly conserved regions among eight different class 3 sequences. These two variable regions of 15 and 9 amino acids are predicted to be in surface-exposed loops.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335540     DOI: 10.1111/j.1365-2958.1992.tb01784.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  12 in total

1.  DNA Sequence analysis of the PorB protein of nonserotypeable serogroup C ET-15 meningococci suggests a potential mutational hot spot on their serotype antigens.

Authors:  Dennis K S Law; Averil M Henderson; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

2.  Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design.

Authors:  Rachel Urwin; Joanne E Russell; Emily A L Thompson; Edward C Holmes; Ian M Feavers; Martin C J Maiden
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.

Authors:  Kristin H Dyet; Diana R Martin
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

4.  Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.

Authors:  P van der Ley; J van der Biezen; P Hohenstein; C Peeters; J T Poolman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

5.  Correlation between serological and sequencing analyses of the PorB outer membrane protein in the Neisseria meningitidis serotyping system.

Authors:  C T Sacchi; A P Lemos; A M Whitney; C A Solari; M E Brandt; C E Melles; C E Frasch; L W Mayer
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

Review 6.  Molecular techniques for the investigation of meningococcal disease epidemiology.

Authors:  M C Maiden; M Frosch
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

7.  Molecular targets in meningococci: efficient routine characterization and optimal outbreak investigation in conjunction with routine surveillance of the meningococcal group B vaccine candidate, fHBP.

Authors:  Jay Lucidarme; Lynne S Newbold; Jamie Findlow; Stefanie Gilchrist; Stephen J Gray; Anthony D Carr; James Hewitt; Edward B Kaczmarski; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2010-12-01

8.  Sequencing of the porB gene: a step toward a true characterization of Neisseria meningitidis.

Authors:  R Abad; B Alcalá; C Salcedo; R Enríquez; M J Uría; P Diez; J A Vázquez
Journal:  Clin Vaccine Immunol       Date:  2006-10

9.  Analysis of Neisseria meningitidis class 3 outer membrane protein gene variable regions and type identification using genetic techniques.

Authors:  M C Bash; K B Lesiak; S D Banks; C E Frasch
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

Review 10.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.